Is high-dose stereotactic body radiotherapy (SBRT) for stage i non-small cell lung cancer (NSCLC) overkill? A systematic review

Angela Van Baardwijk, Wolfgang A. Tomé, Wouter Van Elmpt, Soren M. Bentzen, Bart Reymen, Rinus Wanders, Ruud Houben, Michel Öllers, Philippe Lambin, Dirk De Ruysscher

Research output: Contribution to journalArticlepeer-review

78 Scopus citations

Fingerprint Dive into the research topics of 'Is high-dose stereotactic body radiotherapy (SBRT) for stage i non-small cell lung cancer (NSCLC) overkill? A systematic review'. Together they form a unique fingerprint.

Medicine & Life Sciences